| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AFRC & MRC Neuropathogenesis Unit, West Mains Road, Edinburgh EH9 3JF, U.K.
There are many distinct strains of scrapie agent, identified by their relative incubation periods and quantitative and qualitative neuropathological properties in inbred mice of particular genotypes. When serially passaged under specified conditions of mouse strain, route of infection and dose of infectivity these properties are stable. However, they may change in a predictable manner if the passage strategy is altered. The scrapie strain 87A shows what has previously been defined as Class III stability; it is stable when passaged at low dose in C57BL mice, but often suddenly changes its properties in the course of a single passage if high doses are used, always resulting in the same new strain. The latter, designated 7D, has shorter incubation periods and more extensive pathology than 87A, properties which are subsequently stable on serial passage even at high dose. This phenomenon has been seen repeatedly using scrapie isolates from six different natural cases in five different breeds of sheep. These isolates are closely similar in all their properties, showing them to be independent isolations of the 87A strain; there have been no isolations of 87A in which the phenomenon did not occur. On the other hand, none of the many other scrapie strains used in the same laboratory have shown this change. 87A brain samples consistently behave as if they contain 87A together with a smaller amount of 7D. This is so even after 87A has previously been passaged at high dilution, well beyond the limiting dilution for 7D, a procedure which would eliminate any minor agent strain originally present in the isolate. Therefore it is highly likely that the 7D in tissues of mice infected with 87A is generated de novo at each passage by mutational change from 87A during the incubation period. The established fact that many different strains exist and the considerable evidence that mutation can occur lead to the conclusion that scrapie agent has its own independently replicating genome.
Received 16 June 1986;
accepted 15 September 1986.
This article has been cited by other articles:
|
|
 |
|
  J. G. Jacobs, J. P. M. Langeveld, A.-G. Biacabe, P.-L. Acutis, M. P. Polak, D. Gavier-Widen, A. Buschmann, M. Caramelli, C. Casalone, M. Mazza, et al. Molecular Discrimination of Atypical Bovine Spongiform Encephalopathy Strains from a Geographical Region Spanning a Wide Area in Europe J. Clin. Microbiol., June 1, 2007; 45(6): 1821 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lezmi, A. Bencsik, and T. Baron PET-blot Analysis Contributes to BSE Strain Recognition in C57Bl/6 Mice J. Histochem. Cytochem., October 1, 2006; 54(10): 1087 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Safar, K. Kellings, A. Serban, D. Groth, J. E. Cleaver, S. B. Prusiner, and D. Riesner Search for a Prion-Specific Nucleic Acid J. Virol., August 15, 2005; 79(16): 10796 - 10806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Somerville, S. Hamilton, and K. Fernie Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc J. Gen. Virol., January 1, 2005; 86(1): 241 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Baron, C. Crozet, A.-G. Biacabe, S. Philippe, J. Verchere, A. Bencsik, J.-Y. Madec, D. Calavas, and J. Samarut Molecular Analysis of the Protease-Resistant Prion Protein in Scrapie and Bovine Spongiform Encephalopathy Transmitted to Ovine Transgenic and Wild-Type Mice J. Virol., June 15, 2004; 78(12): 6243 - 6251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Arjona, L. Simarro, F. Islinger, N. Nishida, and L. Manuelidis Two Creutzfeldt-Jakob disease agents reproduce prion protein-independent identities in cell cultures PNAS, June 8, 2004; 101(23): 8768 - 8773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Q. Zou, J. Zheng, D. M. Gray, P. Gambetti, and S. G. Chen Antibody to DNA detects scrapie but not normal prion protein PNAS, February 3, 2004; 101(5): 1380 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aguzzi and C. Haass Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease Science, October 31, 2003; 302(5646): 814 - 818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nonno, E. Esposito, G. Vaccari, M. Conte, S. Marcon, M. Di Bari, C. Ligios, G. Di Guardo, and U. Agrimi Molecular Analysis of Cases of Italian Sheep Scrapie and Comparison with Cases of Bovine Spongiform Encephalopathy (BSE) and Experimental BSE in Sheep J. Clin. Microbiol., September 1, 2003; 41(9): 4127 - 4133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Gambetti, Q. Kong, W. Zou, P. Parchi, and S. G Chen Sporadic and familial CJD: classification and characterisation Br. Med. Bull., June 1, 2003; 66(1): 213 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Horiuchi, T. Nemoto, N. Ishiguro, H. Furuoka, S. Mohri, and M. Shinagawa Biological and Biochemical Characterization of Sheep Scrapie in Japan J. Clin. Microbiol., September 1, 2002; 40(9): 3421 - 3426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Somerville, R. C. Oberthur, U. Havekost, F. MacDonald, D. M. Taylor, and A. G. Dickinson Characterization of Thermodynamic Diversity between Transmissible Spongiform Encephalopathy Agent Strains and Its Theoretical Implications J. Biol. Chem., March 22, 2002; 277(13): 11084 - 11089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Bruce, A. Boyle, S. Cousens, I. McConnell, J. Foster, W. Goldmann, and H. Fraser Strain characterization of natural sheep scrapie and comparison with BSE J. Gen. Virol., March 1, 2002; 83(3): 695 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Narang A Critical Review of the Nature of the Spongiform Encephalopathy Agent: Protein Theory Versus Virus Theory Experimental Biology and Medicine, January 1, 2002; 227(1): 4 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schlumpberger, S. B. Prusiner, and I. Herskowitz Induction of Distinct [URE3] Yeast Prion Strains Mol. Cell. Biol., October 15, 2001; 21(20): 7035 - 7046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Korth, B. C. H. May, F. E. Cohen, and S. B. Prusiner Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease PNAS, August 14, 2001; 98(17): 9836 - 9841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Prusiner Neurodegenerative Diseases and Prions N. Engl. J. Med., May 17, 2001; 344(20): 1516 - 1526. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Peretz, M. R. Scott, D. Groth, R. A. Williamson, D. R. Burton, F. E. Cohen, and S. B. Prusiner Strain-specified relative conformational stability of the scrapie prion protein Protein Sci., April 1, 2001; 10(4): 854 - 863. [Abstract] [Full Text]
|
|
|
|
|
|
C. Korth, K. Kaneko, and S. B. Prusiner Expression of unglycosylated mutated prion protein facilitates PrPSc formation in neuroblastoma cells infected with different prion strains J. Gen. Virol., October 1, 2000; 81(10): 2555 - 2563. [Abstract] [Full Text]
|
|
|
|
|
|
J. C. Bartz, R. A. Bessen, D. McKenzie, R. F. Marsh, and J. M. Aiken Adaptation and Selection of Prion Protein Strain Conformations following Interspecies Transmission of Transmissible Mink Encephalopathy J. Virol., June 15, 2000; 74(12): 5542 - 5547. [Abstract] [Full Text]
|
|
|
|
|
|
T. Sweeney, T. Kuczius, M. McElroy, M. G. Parada, and M. H. Groschup Molecular analysis of Irish sheep scrapie cases J. Gen. Virol., June 1, 2000; 81(6): 1621 - 1627. [Abstract] [Full Text]
|
|
|
|
|
|
G. M. Shaked, G. Fridlander, Z. Meiner, A. Taraboulos, and R. Gabizon Protease-resistant and Detergent-insoluble Prion Protein Is Not Necessarily Associated with Prion Infectivity J. Biol. Chem., June 18, 1999; 274(25): 17981 - 17986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Prusiner Prions PNAS, November 10, 1998; 95(23): 13363 - 13383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. B. Prusiner Prion Diseases and the BSE Crisis Science, October 10, 1997; 278(5336): 245 - 251. [Abstract] [Full Text]
|
|
|
|
|
|
L. Manuelidis, W. Fritch, and Y. Xi Evolution of a Strain of CJD That Induces BSE-Like Plaques Science, July 4, 1997; 277(5322): 94 - 98. [Abstract] [Full Text]
|
|
|
|
|
|
G. C. Telling, P. Parchi, S. J. DeArmond, P. Cortelli, P. Montagna, R. Gabizon, J. Mastrianni, E. Lugaresi, P. Gambetti, and S. B. Prusiner Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity Science, December 20, 1996; 274(5295): 2079 - 2082. [Abstract] [Full Text]
|
|
|
|
 |
|
 R Hecker, A Taraboulos, M Scott, K M Pan, S L Yang, M Torchia, K Jendroska, S J DeArmond, and S B Prusiner Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes & Dev., July 1, 1992; 6(7): 1213 - 1228. [Abstract] [PDF]
|
|
|
|
|
|
S. Prusiner Molecular biology of prion diseases Science, June 14, 1991; 252(5012): 1515 - 1522. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
